Retinal Proteomics of a Mouse Model of Dystroglycanopathies Reveals Molecular Alterations in Photoreceptors

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10045/115287
Información del item - Informació de l'item - Item information
Título: Retinal Proteomics of a Mouse Model of Dystroglycanopathies Reveals Molecular Alterations in Photoreceptors
Autor/es: Uribe, Mary Luz | Martín-Nieto, José | Quereda, Cristina | Rubio-Fernández, Marcos | Cruces, Jesús | Janssen, George M.C. | de Ru, Arnoud H. | van Veelen, Peter A. | Hensbergen, Paul J.
Grupo/s de investigación o GITE: Genética Humana y de Mamíferos (GHM)
Centro, Departamento o Servicio: Universidad de Alicante. Departamento de Fisiología, Genética y Microbiología | Universidad de Alicante. Instituto Multidisciplinar para el Estudio del Medio "Ramón Margalef"
Palabras clave: Mass spectrometry | Retina | POMT1 | Outer segments | KIAA1549 | MDDG
Área/s de conocimiento: Genética
Fecha de publicación: 23-may-2021
Editor: American Chemical Society
Cita bibliográfica: Journal of Proteome Research. 2021, 20(6): 3268-3277. https://doi.org/10.1021/acs.jproteome.1c00126
Resumen: Mutations in the POMT1 gene, encoding a protein O-mannosyltransferase essential for α-dystroglycan (α-DG) glycosylation, are frequently observed in a group of rare congenital muscular dystrophies, collectively known as dystroglycanopathies. However, it is hitherto unclear whether the effects seen in affected patients can be fully ascribed to α-DG hypoglycosylation. To study this, here we used comparative mass spectrometry-based proteomics and immunofluorescence microscopy and investigated the changes in the retina of mice in which Pomt1 is specifically knocked out in photoreceptor cells. Our results demonstrate significant proteomic changes and associated structural alteration in photoreceptor cells of Pomt1 cKO mice. In addition to the effects related to impaired α-DG O-mannosylation, we observed morphological alterations in the outer segment that are associated with dysregulation of a relatively understudied POMT1 substrate (KIAA1549), BBSome proteins, and retinal stress markers. In conclusion, our study provides new hypotheses to explain the phenotypic changes that are observed in the retina of patients with dystroglycanopathies.
Patrocinador/es: Our studies were supported, in part, by the Institute of Health Carlos III grants PI12/0157 and PI15/073 (to J.C. and J.M.-N.), and by the Comunidad de Madrid (“VISIONANIMAL” Biomedicine project S2010/BMD2439 to J.C.) all of them co-financed by the European Regional Development Fund (ERDF/FEDER). Additional research funding was provided by the Universidad de Alicante through grants for use of technical/research facilities (UAUSTI19-17 to J.M.-N.), scientific productivity (VIGROB-237 to J.M.-N.), and a short stay abroad (UAEEBB2015FPU-14 to M.L.U.).
URI: http://hdl.handle.net/10045/115287
ISSN: 1535-3893 (Print) | 1535-3907 (Online)
DOI: 10.1021/acs.jproteome.1c00126
Idioma: eng
Tipo: info:eu-repo/semantics/article
Derechos: © 2021 The Authors. Published by American Chemical Society. Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0)
Revisión científica: si
Versión del editor: https://doi.org/10.1021/acs.jproteome.1c00126
Aparece en las colecciones:INV - GHM - Artículos de Revistas

Archivos en este ítem:
Archivos en este ítem:
Archivo Descripción TamañoFormato 
ThumbnailUribe_etal_2021_JProteomeRes.pdf4,9 MBAdobe PDFAbrir Vista previa


Este ítem está licenciado bajo Licencia Creative Commons Creative Commons